|
2025
|
Invention
|
Neutralizing anti-influenza b antibodies and uses thereof.
The invention relates to antibodies a... |
|
|
Invention
|
Antibodies that neutralize hepatitis b virus and uses thereof.
The present disclosure relates to... |
|
2024
|
Invention
|
Anti-o1 antibodies and uses thereof.
The present disclosure provides binding proteins (e.g., ant... |
|
|
Invention
|
Antibody directed against s. aureus clumping factor a (clfa).
The present disclosure is directed... |
|
|
Invention
|
Coronavirus compositions and uses thereof. Provided herein are engineered coronavirus polypeptide... |
|
|
Invention
|
Multispecific antibodies specifically binding to zika virus epitopes and uses thereof.
The inven... |
|
|
Invention
|
Neutralizing anti-influenza a antibodies and uses thereof.
The invention relates to antibodies a... |
|
2023
|
Invention
|
Engineered anti-sars-cov-2 antibodies and methods of using the same. The instant disclosure provi... |
|
|
Invention
|
Engineered anti-sars-cov-2 antibodies and uses thereof. The instant disclosure provides antibodie... |
|
|
Invention
|
Using sparse electronic health records for predicting health outcome. EHR data records often incl... |
|
|
Invention
|
Neutralizing anti-influenza b antibodies and uses thereof. The invention relates to antibodies an... |
|
|
Invention
|
Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof.
The in... |
|
|
Invention
|
Broadly neutralizing antibodies against rsv and mpv paramyxoviruses. The instant disclosure provi... |
|
|
Invention
|
Antibodies that bind to multiple sarbecoviruses. The instant disclosure provides antibodies and a... |
|
|
Invention
|
Anti-parvovirus antibodies and uses thereof. e.g.e.g. parvovirus B19 and can neutralize a parvovi... |
|
|
Invention
|
Broadly neutralizing antibodies against influenza neuraminidase. The instant disclosure provides ... |
|
|
Invention
|
Combination immunotherapy for influenza. in vivo in vivo half-life of the antibody or antigen-bin... |
|
2022
|
Invention
|
Engineered compositions. Provided herein are engineered coronavirus polypeptides, polynucleotides... |
|
|
Invention
|
Anti-o2 antibodies and uses thereof. Klebsiella pneumoniae 02 binding proteins, (e.g., antibodies... |
|
|
Invention
|
Antibodies that potently neutralize hepatitis b virus and uses thereof. The present invention rel... |
|
|
Invention
|
Engineered polypeptides. Provided herein are engineered polypeptides (e.g., Fc polypeptides, Fc p... |
|
|
Invention
|
Antibodies against respiratory syncytial virus, human metapneumovirus and pneumonia virus of mice... |
|
2021
|
Invention
|
Antibodies binding to f-protein of metapneumovirus and uses thereof.
The present invention relat... |
|
|
Invention
|
Antibodies binding to f-protein of metapneumovirus and uses thereof. The present invention relate... |
|
|
Invention
|
Antibodies and methods for treatment of influenza a infection. The present disclosure provides an... |
|
|
Invention
|
Antibodies that bind to multiple betacoronaviruses. The instant disclosure provides antibodies an... |
|
|
Invention
|
Antibodies against influenza a viruses.
The instant disclosure provides antibodies and antigen-b... |
|
|
Invention
|
Anti-influenza antibodies and combinations thereof.
The present disclosure relates, in part, to ... |
|
|
Invention
|
Broadly neutralizing antibodies against influenza neuraminidase.
The instant disclosure provides... |
|
|
Invention
|
Anti-influenza antibodies and combinations thereof. The present disclosure relates, in part, to a... |
|
|
Invention
|
Antibodies against influenza a viruses. The instant disclosure provides antibodies and antigen-bi... |
|
|
Invention
|
Neutralizing anti-influenza a antibodies and uses thereof. The invention relates to antibodies an... |
|
|
Invention
|
Antibodies against sars-cov-2. The instant disclosure provides antibodies and antigen-binding fra... |
|
|
Invention
|
S. aureus clumping factor a (clfa). S. aureus alpha toxin (AT) protein to a subject. Bispecific m... |
|
|
Invention
|
Anti-o1 antibodies and uses thereof. Klebsiella pneumoniae O1 binding proteins, (e.g., antibodies... |
|
|
Invention
|
Engineered hepatitis b virus neutralizing antibodies and uses thereof. The present disclosure rel... |
|
|
Invention
|
Staphylococcus aureus leukotoxins. Staphylococcus aureus infections. |
|
|
Invention
|
Structure-guided immunotherapy against sars-cov-2. The instant disclosure provides antibodies and... |
|
|
Invention
|
Novel antibodies specifically binding to zika virus epitopes and uses thereof.
The invention rel... |
|
|
Invention
|
Antibodies specifically binding to zika virus epitopes and uses thereof. The invention relates to... |
|
|
Invention
|
Antibodies against sars-cov-2 and methods of using the same. The instant disclosure provides anti... |
|
2020
|
Invention
|
Antibodies binding to plasmodium circumsporozoite protein and uses thereof.
The present inventio... |
|
|
Invention
|
Antibodies and methods for treatment of influenza a infection.
The present invention provides an... |
|
2019
|
Invention
|
Combination hbv therapy. The present disclosure provides methods for treating HBV infection using... |
|
|
Invention
|
Antibodies that neutralize hepatitis b virus and uses thereof. The present disclosure relates to ... |
|
|
Invention
|
Antibodies and methods for treatment of lyssavirus infection.
The invention provides antibodies,... |
|
2016
|
P/S
|
Chemical products for industrial or scientific purposes; reagents for laboratory purposes. Pharma... |
